About Huntsman Cancer Institute

Huntsman Cancer Institute, located in Salt Lake City, Utah, is a world-leader in cancer genetics, with a focus of researching cancer, informing the public about cancer risk, and treating cancer using cutting edge technologies and research. Utah is uniquely positioned to unlock critical secrets about cancer that will be key to eradicating this disease from the face of the earth.  Utah researchers have already used these unparalleled assets to identify genetic mutations that cause breast cancer, ovarian cancer, colon cancer, melanoma and many others.  Indeed, more inherited human disease genes have been discovered in Utah than anywhere else in the world.  These discoveries have saved—and continue to save—countless lives.  Accelerating our research capacity exponentially to provide hope for families who have been plagued, generation after generation, by predispositions to cancer. Our generous benefactor, the Huntsman family ensures that 100% of your donation funds critical cancer research.  Funds from the Miles 2 Give 2014 Tour fund sarcoma research at Huntsman Cancer Institute.

Your Donation At Work

Huntsman Cancer Institute’s Sarcoma Team

Stephen L. Lessnick, M.D., Ph.D.

Stephen Lessnick, MD, PhD, is a Huntsman Cancer Institute (HCI) investigator and member of the Nuclear Control of Cell Growth and Differentiation program. He is a Professor in the Division of Pediatric Hematology/Oncology, Department of Pediatrics at the University of Utah School of Medicine, as well as an Adjunct Professor in the Department of Oncological Sciences, and an Adjunct Professor in the Department of Bioengineering. He is the Director of the Center for Children’s Cancer Research. He holds a Jon and Karen Huntsman Presidential Professorship in Cancer Research.

The Lessnick Lab studies Ewing’s sarcoma as a model for pediatric tumor development. Ewing’s sarcoma is a prototypical tumor that has a peak incidence in the teenage years. A chromosomal translocation (an abnormality that occurs when chromosomes break and the fragments rejoin to other chromosomes) characterizes Ewing’s sarcoma. Learning details of how the cancer-causing protein created by this translocation functions could help resolve questions about the differences between pediatric and adult tumors, and between sarcomas and other forms of cancer. Additionally, the Lessnick Lab is interested in developing new therapeutic interventions for children with cancer.

Dr. Lessnick earned his bachelor’s degree from Brandeis University followed by MD and PhD degrees from the University of California, Los Angeles (UCLA) as part of the Medical Scientist Training Program (MSTP). He conducted his internship and residency at Children’s Hospital in Boston, Massachusetts, followed by a fellowship in pediatric hematology/oncology at the Dana-Farber Cancer Institute and Children’s Hospital. His fellowship/postdoctoral research was performed in the Pediatric Oncology Department at the Dana-Farber Cancer Institute.

Kevin B. Jones, M.D.

Specializing in the evaluation, diagnosis, and surgical management of sarcomas, tumors arising in bone and soft-tissue, Dr. Jones sees both pediatric and adult patients. His practice also includes surgery for benign bone tumors such as giant cell tumor of bone, chondromyxoid fibroma, osteochondromas, and others as well as stabilization of the bones with metastatic disease from other cancers causing pathologic fractures or impending fractures. Children and adults in need of resection and reconstruction for osteosarcoma, Ewing’s sarcoma, chondrosarcoma, synovial sarcoma, liposarcoma, and leiomyosarcoma of the extremities and pelvis come from all across the mountain west to see Dr. Jones and the multidisciplinary team approach used by Sarcoma Services at the Huntsman Cancer Institute. Weekly meetings bring together surgeons, chemotherapy specialists, radiation oncologists, pathologists, radiologists, and other providers to discuss every new case of sarcoma. Dr. Jones emphasizes clear communication and educates and empowers patients to make wise choices with regard to their cancer care. He studied English literature at Harvard and received his medical degree from Johns Hopkins University. After orthopaedic residency training at the University of Iowa, he specialized in musculoskeletal oncology through fellowship training at the University of Toronto, Mount Sinai and Princess Margaret Hospitals.

R. Lor Randall, M.D., FACS

R. Lor Randall, MD, FACS, is the Director of Sarcoma Services at the University of Utah’s Huntsman Cancer Institute and Primary Children’s Medical Center. He is a Professor of Orthopaedics and The L.B. & Olive S. Young Endowed Chair for Cancer Research. Randall has an international reputation in sarcoma surgery and care, working with clinician-scientists throughout the world to develop the best treatments possible for sarcoma patients of all ages. He is the recipient of numerous national and international awards and holds leadership positions in multiple medical and surgical societies.

Rate this post